Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial (Q28265484)

2

0 references

U Kalina

3

0 references

S Knaub

4

0 references

A Nagy

5

0 references

H Ostermann

Journal of Thrombosis and Haemostasis

6

0 references

language of work or name

English

0 references

publication date

April 2008

0 references

published in

0 references

volume

6

0 references

issue

4

0 references

page(s)

622-31

0 references

cites work

Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?

1 reference

https://api.crossref.org/works/10.1111/J.1538-7836.2008.02904.X

Management and prognostic features of intracerebral hemorrhage during anticoagulant therapy: a Swedish multicenter study

21 April 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02904.X

The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02904.X

Guidelines on oral anticoagulation (warfarin): third edition--2005 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02904.X

Prothrombin complex concentrate for oral anticoagulant reversal in neurosurgical emergencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02904.X

Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02904.X

The management of coumarin-induced over-anticoagulation Annotation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02904.X

Anticoagulants and their reversal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02904.X

Progression of warfarin-associated intracerebral hemorrhage after INR normalization with FFP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02904.X

Urgent reversal of warfarin with prothrombin complex concentrate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02904.X

Clinical use of plasma and plasma fractions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02904.X

Beriplex P/N reverses severe warfarin-induced overanticoagulation immediately and completely in patients presenting with major bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02904.X

Rapid reversal of oral anticoagulation with warfarin by a prothrombin complex concentrate (Beriplex): efficacy and safety in 42 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02904.X

Successful emergency reversal of phenprocoumon anticoagulation with prothrombin complex concentrate: a prospective clinical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02904.X

Efficacy and safety of a prothrombin complex concentrate with two virus-inactivation steps in patients with severe liver damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02904.X

Measurement of bleeding severity: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02904.X

Prothrombin complex concentrate (Octaplex) in patients requiring immediate reversal of oral anticoagulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02904.X

Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02904.X

Efficacy and safety of a prothrombin complex concentrate (Octaplex) for rapid reversal of oral anticoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02904.X

Therapeutic quality control of oral anticoagulant therapy comparing the short-acting acenocoumarol and the long-acting phenprocoumon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02904.X

Thrombogenicity of prothrombin complex concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02904.X

Effectiveness of alternative treatments for reducing potential viral contaminants from plasma-derived products

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02904.X

Optimisation of the prothrombin complex concentrate dose for warfarin reversal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02904.X

Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02904.X

American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02904.X